PATENT CLAIM ANALYSIS

Application Number: 15870557
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "230500"]

Abstract:
The present invention relates to substituted heterocyclic derivative compounds, compositions comprising said compounds, and the use of said compounds and compositions for epigenetic regulation by inhibition of bromodomain-mediated recognition of acetyl lysine regions of proteins, such as histones. Said compositions and methods are useful for the treatment of cancer and neoplastic disease.

Claim (Index 34):
The compound of  claim 33 , or a pharmaceutically acceptable salt thereof, wherein G is:

Metadata:
- Claim Count in Document: 4.0
- Percentile: 86.0
- Lexical Diversity: 1.425
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15130503', '14517705', '15488674', '14658048', '14789881']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8561482330466864
- 35 USC 102 Novelty (BERT): 0.5739915097695407
- Combined Prediction Score: 0.8279325607189718
- Mean Citation Score: 490.161302
- Max Citation Score: 508.7241
- Similarity Product: 375.59074308282135

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test